• GKT137831 for Nox1/Nox4 Redox Workflows

  2026-09-15

  GKT137831 enables pathway-proximal testing of Nox1/Nox4-driven oxidative stress across pulmonary vascular, fibrotic, and metabolic disease models. This guide combines concentration planning, orthogonal ROS readouts, membrane-injury assays, and troubleshooting strategies to distinguish upstream redox control from late ferroptosis events.

• EZ Cap Cy5 Firefly Luciferase mRNA: Readout Logic

  2026-09-15

  EZ Cap Cy5 Firefly Luciferase mRNA enables researchers to distinguish mRNA delivery from productive translation using complementary fluorescence and bioluminescence signals. This article presents a mechanistic framework for assay design, carrier comparison, and translational interpretation beyond conventional dual-reporter workflows.

• Indomethacin Workflows for AKI Inflammation Research

  2026-09-14

  Indomethacin provides a practical COX-centered perturbation tool for separating prostaglandin-linked inflammation from the FXR–KLF11–JAK2/STAT3 mechanism reported in contrast-induced acute kidney injury. This guide translates the reference findings into cell-based assay design while extending the compound’s use to lipid metabolism study and membrane signaling modulation.

• Tauroursodeoxycholic Acid: ER Stress Workflows

  2026-09-14

  Tauroursodeoxycholic Acid, or TUDCA, is a practical chemical-chaperone tool for separating ER stress, mitochondrial injury, apoptosis, and autophagy in disease models. This guide translates ER stress findings from subarachnoid hemorrhage research into controlled cell-based workflows, assay choices, and troubleshooting strategies.

• Separating Growth Arrest from Cell Death in Cancer Assays

  2026-09-13

  Schwartz’s dissertation distinguishes relative viability from fractional viability, showing why a single in vitro endpoint can obscure whether a cancer drug primarily slows proliferation, induces cell death, or does both. Its timing- and response-oriented framework supports more rigorous interpretation of checkpoint-directed therapies and drug combinations.

• Sulfo-Cy3 NHS Ester: Hydrophilic Fluorescent Dye

  2026-09-12

  Sulfo-Cy3 NHS Ester is a hydrophilic fluorescent dye for aqueous labeling of primary amines in proteins and peptides. Its sulfonated structure, Cy3 spectral profile, and NHS ester chemistry support protein conjugation workflows for soluble and challenging biomolecular targets.

• Cy5 amine (non-sulfonated): Labeling Guide

  2026-09-11

  Cy5 amine (non-sulfonated) provides a primary amine for covalent attachment of a red-shifted cyanine fluorophore to activated biomolecule partners. It is suited to organic or mixed-solvent labeling workflows, but is insoluble in water and should not be used for direct aqueous dissolution, diagnostic testing, or medical applications.

• Griseofulvin: From Fungal Mitosis to Assays

  2026-09-11

  Explore how Griseofulvin functions as a microtubule associated inhibitor and how mechanism-resolved cytometry can sharpen antifungal drug research. This guide connects product handling, fungal mitosis biology, and aneugenic assay interpretation without conflating distinct experimental domains.

• Haloprogin: Applied Antifungal Research Workflows

  2026-09-10

  Haloprogin supports reproducible profiling across dermatophytes, Candida, and selected Gram-positive bacteria, with workflows spanning MIC/MFC testing and topical infection models. Its solvent, matrix, and formulation behavior make assay design especially important when translating in vitro potency into topical efficacy.

• rTMS, GABAergic Neurons, and Amyloid Clearance in AD

  2026-09-10

  This study identifies a cellular pathway linking repetitive transcranial magnetic stimulation to amyloid clearance and cognitive recovery in a 5xFAD Alzheimer’s disease model. Its central finding is that rTMS activates GABAergic neurons, increases Cx3cl1-Cx3cr1 signalling, and promotes microglial phagocytosis while reducing plaque burden and neuroinflammatory features.

• Cy5 Maleimide for Protein Labeling and Condensate Imaging

  2026-09-09

  Cy5 maleimide enables site-selective cysteine labeling for far-red protein tracking, microscopy, and biomolecular-condensate assays. Its non-sulfonated format is especially useful when researchers need to test how fluorophore chemistry influences molecular partitioning rather than treating every dye as an inert tag.

• Ciprofloxacin Hydrochloride: Mechanism and Uses

  2026-09-09

  Ciprofloxacin hydrochloride is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV. Evidence also supports research into inhalational anthrax treatment, antibiotic-combination antagonism, and immunomodulatory effects, but animal and in vitro findings do not establish new clinical indications.

• A-1331852: Precision BCL-XL Inhibition

  2026-09-08

  A-1331852 is a selective BCL-XL inhibitor for mapping apoptotic dependence, validating BCL-XL–BIM complex disruption, and testing senolytic strategies in cancer models. This guide translates published BH3-mimetic findings into practical dose-response, apoptosis, and troubleshooting workflows.

• hCG, H3K27 Methylation, and CXCL10 in Decidua

  2026-09-08

  The reference study shows that human chorionic gonadotropin suppresses CXCL10 in human decidual stromal cells by promoting EZH2-dependent H3K27 trimethylation at the CXCL10 promoter. This connects placental endocrine signaling with chromatin control of immune-cell recruitment and provides a mechanistic framework for studying maternal–fetal immune tolerance.

• Biotin-16-UTP: From RNA Labels to Mechanism

  2026-09-07

  Biotin-16-UTP connects biotin-labeled RNA synthesis with mechanistic questions in cancer biology. Using the LINC02870–EIF4G1–SNAIL axis in hepatocellular carcinoma as an anchor, this article outlines how translational researchers can use affinity-enabled RNA workflows to validate RNA-protein interactions while managing assay, interpretation, and clinical-translation risks.

7789 records 1/520 page Next 12345 下5页 Last page